Why the study?
Does the E/Em ratio predict all-cause mortality and cardiovascular death in patients with end-stage renal disease?
Population
220 patients with end-stage renal disease
Design
Cohort
Follow-up
median 48 months
Authors
Loading...
E/Em ratio may aid mortality risk stratification in ESRD; leaves open whether it guides therapy or improves outcomes.
Does the E/Em ratio predict all-cause mortality and cardiovascular death in patients with end-stage renal disease?
Wang et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: